Pharmaxis Pharmaceuticals Ltd named in advertisements for breaches of the ABPI Code of Practice

Pharmaxis Pharmaceuticals Ltd has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.

Pharmaxis – Case AUTH/2643/10/13
For failing to correctly categorize a series of materials as either promotional or non-promotional at the outset, and to thus correctly certify them, together with failing to certify the final form of promotional material, Pharmaxis was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence

in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards

Clause 14.1 - Failing to certify material in its final form

Clause 14.3 - Failing to certify a medical and educational good and service

Clause 14.3 - Certifying a promotional medical and educational good and

service.

The full case report was published in the PMCPA May Code of Practice Review and is also available at www.pmcpa.org.uk.

The advertisements will appear in the BMJ and The Pharmaceutical Journal on 14 June 2014, The Nursing Standard on 18 June 2014.